Aurinia Pharmaceuticals
AUPH
#5387
Rank
S$1.47 B
Marketcap
$10.73
Share price
5.30%
Change (1 day)
38.53%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -S$20.8 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are S$0.22 Billion. In 2023 the company made an earning of -S$0.11 Billion, an increase over its 2022 earnings that were of -S$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$20.8 Million-79.38%
2023 -S$0.11 Billion-31.8%
2022 -S$0.15 Billion-39.4%
2021 -S$0.25 Billion61.9%
2020 -S$0.16 Billion-9.73%
2019 -S$0.17 Billion92.65%
2018 -S$86.65 Million36.39%
2017 -S$63.53 Million106.29%
2016 -S$30.8 Million-15.4%
2015 -S$36.4 Million65.84%
2014 -S$21.95 Million129.82%
2013 -S$9.55 Million-26.6%
2012 -S$13.02 Million
2010 -S$7.37 Million-39.22%
2009 -S$12.13 Million-43.78%
2008 -S$21.56 Million-53.19%
2007 -S$46.06 Million42.97%
2006 -S$32.22 Million-23.03%
2005 -S$41.86 Million36.1%
2004 -S$30.76 Million172.57%
2003 -S$11.29 Million484.61%
2002 -S$1.94 Million
2000 -S$9.17 Million453.81%
1999 -S$1.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$6.45 B-31,667.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$7.41 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$29.86 Million 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA